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Scheme 1. Synthesis of tetrazoles. Reagents and conditions: NaN3 NH4
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Unexpected reaction
Pyrazolo[3,4-d]pyrimidine
Tetrazole
CycloadditionIn this Letter, we described the synthesis of new 5-(5-amino-1-aryl-1H-pyrazole-4-yl)-1H-tetrazoles
2a–c from 5-amino-1-aryl-1H-pyrazole-4-carbonitriles 1a–c as well as the unexpected 1H-pyrazol-
o[3,4-d]pyrimidine derivatives 6a–c from 5-amino-1-aryl-3-methyl-1H-pyrazole-4-carbonitriles 4a–c,
instead of 5-(5-amino-1-aryl-3-methyl-1H-pyrazole-4-yl)-1H-tetrazoles 5a–c as desired. In an attempt
to obtain these tetrazole derivatives containing the methyl group at C3-position in the pyrazole ring,
the amino group in 5-amino-1-(4-methoxyphenyl)-3-methyl-1H-pyrazole-4-carbonitrile 4c was pro-
tected by the reaction with sodium hydride and di-tert-butyl-dicarbonate (Boc). The tetrazole derivative
5c was synthesized from the protected compound 7c using analogue methodology to obtain 2a–c and
6a–c.
 2013 Elsevier Ltd. All rights reserved.RIn recent years, tetrazoles have received considerable attention
because they represent an important class of heterocycles, which
exhibit a wide range of biological activity, including antiprotozoal,
antihypertensive and antibiotic effects.1 Tetrazoles show greater
lipophilicity and hence may serve as non-classical isosteres for
the carboxylic acid group.2 The classical method for the prepara-
tion of 5-substituted tetrazoles occurs through the reaction of
nitriles with sodium azide and ammonium chloride in DMF, at
120–130 C, by an [3+2] cycloaddition.3 Recently, our research
group reported the synthesis of new 5-(1-aryl-1H-pyrazole-4-yl)-
1H-tetrazoles from 1-aryl-1H-pyrazole-4-carbonitriles, sodium
azide and ammonium chloride in DMF as solvent, for 14 h at
120–130 C.4 In the course of our search for new tetrazole
derivatives, we prepared three new 5-(5-amino-1-aryl-1H-pyra-
zole-4-yl)-1H-tetrazoles 2a–c using analogue methodology
(Scheme 1). 5-Amino-1-aryl-1H-pyrazole-4-carbonitriles 1a–c
were reacted with sodium azide (2 equiv) and ammonium chloride
(2 equiv) in DMF at 130–140 C. After 16–18 h tetrazoles 2a–c
were isolated in good yields: 62–74%. Lower temperatures resulted
in long time reaction.
We have also investigated the inﬂuence of the methyl group at
C3-position in the pyrazole ring. In an attempt to synthesize new
tetrazoles from 5-amino-1-aryl-3-methyl-1H-pyrazole-4-carbo-
nitriles 4a–c, employing the same methodology, the desired
compounds 5-(5-amino-1-aryl-3-methyl-1H-pyrazole-4-yl)-1H-Cl, DMF,
N
N
CN
NH2
N
N NH2
NH
N
N
N
N
N
N
N
H2N
N
N
H2N
R
R
R
Products desired
R
Products obtained
R= 4-F, 4-Br, 4-OCH3
4a-c
5a-c
6a-c
Scheme 2. The reaction leading to the synthesis of 1H-pyrazolo[3,4-d] pyrimidines.
Reagents and conditions: NaN3 NH4Cl, DMF, 120–130 C, 48 h.
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alternative methodologies. When we worked with sodium azide
and ammonium chloride in DMF at 120–130 C for 48 h, unex-
pected products were isolated (Scheme 2). After puriﬁcation by
recrystallization, FT-IR spectra data showed C@N band as well as
NH2 bands. However, in 1H NMR spectroscopy it was found in each
compound two singlet signals related to the methyl group: 2.66–
2.67 ppm and 2.71–2.72 ppm. Besides, two aryl groups were
identiﬁed in aromatic region. The 13C NMR analysis showed signals
corresponding to 1H-pyrazolo[3,4-d]pyrimidine system. In mass
spectra (ESI–MS) the mass/charge ratio values of molecular ion
peaks obtained were higher than expected for the derivatives
5a–c. According to all analytical results, 6-(5-amino-1-aryl-3-
methyl-1H-pyrazol-4-yl)-1-aryl-3-methyl-1H-pyrazolo[3,4-d]pyr-
imidin-4-amine derivatives 6a–cwere isolated. Since the analogues
5-(5-amino-1-aryl-1H-pyrazole-4-yl)-1H-tetrazoles 2a–c were ob-
tained, as mentioned above, the presence of the methyl group at
C3-position in the pyrazole ring affects the reaction. We have also
examined the inﬂuence of ammonium chloride and sodium azideN
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Scheme 3. Synthesis of tetrazoles. Reagents and conditions: (i) NaH, Boin this reaction. When we worked with 5-amino-1-aryl-3-methyl-
1H-pyrazole-4-carbonitriles 4a–c, ammonium chloride (2 equiv)
in DMF the reaction did not proceed. We tried using different
temperatures, from 120 C to under reﬂux, as well as different
reaction times, from 24 h to 48 h. Treatment of 5-amino-1-aryl-3-
methyl-1H-pyrazole-4-carbonitriles 4a–c with sodium azide (2
equiv) in DMF did not generate the desired products using the same
conditions.
With regard to mechanism, the reaction starts by a nucleophilic
attack of the amine group of one molecule to nitrile of another one.
Afterwards, an intramolecular cyclization produces the pyrazol-
o[3,4-d]pyrimidine system. Compounds 6a–c are new, but 1H-pyr-
azolo[3,4-d]pyrimidine obtained from 5-amino-1-aryl-1H-pyrazo
le-4-carbonitriles has been published in the literature. Salaheldin
et al.,5 synthesized 6-(5-amino-1-aryl-1H-pyrazol-4-yl)-1-aryl-
1H-pyrazolo[3,4-d]pyrimidin-4-amine by reacting 5-amino-1-
aryl-1H-pyrazole-4-carbonitriles with triethanolamine and ethanol
under reﬂux for 6 h. Taylor & Borror6 described the synthesis of sim-
ilar products after several hours, using sodium ethoxide and ethanol
in reﬂux. Smith et al.,7 employed potassium t-butoxide, in toluene,
microwave at 160 C.
Since 1H-pyrazolo[3,4-d]pyrimidines present wide applicability
in medicinal chemistry such as being anticancer,8 antibacterial,9
antileishmanial,10 antitrypanosomal,10 and antiviral,11 the biologi-
cal activity of compounds 6a–c will be evaluated.
In another experiment the raw material 5-amino-1-(4-
methoxyphenyl)-3-methyl-1H-pyrazole-4-carbonitrile 4c was re-
acted with sodium hydride and di-tert-butyl-dicarbonate (Boc) to
protect the amino group. The protected product obtained 7c was
treated with sodium azide and ammonium chloride in DMF, at
130–140 C, for 48 h. Analytical results showed that the tetrazole
ring was obtained, the Boc protecting group was removed and
compound 5c was completely characterized (Scheme 3).
In conclusion, the synthesis of new 5-(5-amino-1-aryl-1H-pyra-
zole-4-yl)-1H-tetrazoles 2a–c from 5-amino-1-aryl-1H-pyrazole-
4-carbonitriles 1a–c occurred as expected in good yields. The
presence of the methyl group at C3-position in 5-amino-1-aryl-3-
methyl-1H-pyrazole-4-carbonitriles 4a–c impeded the formation
of analogue tetrazoles 5a–c and the unexpected 1H-pyrazolo[3,4-
d]pyrimidine derivatives 6a–c were isolated. Tetrazole 5c was syn-
thesized employing an alternative synthetic route. In the ﬁrst step,
compound 4c was protected by the reaction with sodium hydride
and di-tert-butyl-dicarbonate (Boc). After that, tetrazole was
obtained using analogue methodology to obtain 2a–c and 6a–c.
Therefore, this synthetic route can be employed to access 5-
(5-amino-1-aryl-3-methyl-1H-pyrazole-4-yl)-1H-tetrazoles 5a–c
planned initially (Scheme 1) and other derivatives from this
system.N
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